EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma.
Ferga C Gleeson, Elizabeth Rajan, Michael J Levy...
https://pubmed.ncbi.nlm.nih.gov/18061597/Actively Recruiting
Led by Erasmus Medical Center · Updated on 2026-09-10
250
Participants Needed
6
Research Sites
4 weeks
Total Duration
Researchers are conducting the POELH-III observational study to evaluate the effectiveness of an improved preoperative endoscopic ultrasound EUS approach in patients with presumed resectable cholangiocarcinoma, including perihilar, intrahepatic, or mid-common bile duct types. This follow-up study builds on earlier POELH-II trial results to better identify lymph node metastases before surgery. The main purpose is to determine how many patients are prevented from surgical work-up due to positive lymph nodes found by EUS-guided tissue sampling. Participants undergo a systematic preoperative endoscopic ultrasound using the enhanced POELH-III EUS protocol. This procedure targets lymph nodes to detect metastases and involves recording all findings during the examination. The study focuses on patients with resectable or unresectable cholangiocarcinoma being considered for liver transplantation. There are no experimental drugs or treatments involved, as the study observes and registers EUS outcomes. Throughout the study, participants data on lymph node status and any complications related to the EUS procedure, including tissue acquisition, are collected and monitored for up to one year. Researchers aim to measure the number of patients who are excluded from surgery based on lymph node findings and track both short-term and long-term complications from the procedure. Participants provide informed consent and are followed according to clinical guidelines, with the study running from early 2026 to late 2028.
CONDITIONS
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
L
Lydi M. J. W. van Driel, MD PhD
D
David M de Jong, MD MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Erasmus Medical Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo a preoperative endoscopic ultrasound using an improved protocol to assess lymph nodes and identify metastases through tissue sampling.
1 or more visits as needed
Duration - Up to 1 year
Researchers monitor participants for short-term and long-term complications from the endoscopic ultrasound procedure and collect outcome data.
Periodic visits or contacts for monitoring
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Ferga C Gleeson, Elizabeth Rajan, Michael J Levy...
https://pubmed.ncbi.nlm.nih.gov/18061597/David M de Jong, Sanne van de Vondervoort, Roy S Dwarkasing...
https://pubmed.ncbi.nlm.nih.gov/36741342/Thomas Malikowski, Michael J Levy, Ferga C Gleeson...
https://pubmed.ncbi.nlm.nih.gov/31860935/David M de Jong, Sanne van de Vondervoort, Roy S Dwarkasing...
https://pubmed.ncbi.nlm.nih.gov/39184062/David M de Jong, Willem J Lammers, Lydi M J W van Driel
https://pubmed.ncbi.nlm.nih.gov/40645595/Alberto Larghi, Mihai Rimbaș, Francesco Ardito...
https://pubmed.ncbi.nlm.nih.gov/32277489/David M de Jong, Caroline M den Hoed, Francois E J A Willemssen...
https://pubmed.ncbi.nlm.nih.gov/37890597/Erasmus Medical Center
Lead Sponsor